Pinuccia Valagussa

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Gianni Luca; Baselga José; Eiermann Wolfgang; Porta Vincente Guillem; Semiglazov Vladimir; Lluch Ana; Zambetti Milvia; Sabadell Dolores; Raab Günther; Cussac Antonio Llombart; Bozhok Alla; Martinez-Agulló Angel; Greco Marco; Byakhov Mikhail; Lopez Juan Josè Lopez; Mansutti Mauro; Valagussa Pinuccia; Bonadonna Gianni
Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
Gianni Luca; Valagussa Pinuccia
Anthracyclines and early breast cancer: the end of an era?
Valagussa Pinuccia
History of adjuvant therapy.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Pinuccia Valagussa (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gianni Luca; Baselga José; Eiermann Wolfgang; Porta Vincente Guillem; Semiglazov Vladimir; Lluch Ana; Zambetti Milvia; Sabadell Dolores; Raab Günther; Cussac Antonio Llombart; Bozhok Alla; Martinez-Agulló Angel; Greco Marco; Byakhov Mikhail; Lopez Juan Josè Lopez; Mansutti Mauro; Valagussa Pinuccia; Bonadonna Gianni
Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(15):2474-81.
2009: Gianni Luca; Valagussa Pinuccia
Anthracyclines and early breast cancer: the end of an era?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(8):1155-7.
2009: Valagussa Pinuccia
History of adjuvant therapy.
Cancer treatment and research 2009;151():3-12.
2008: Bonadonna Gianni; Valagussa Pinuccia; Veronesi Umberto
Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):342-4.
2008: Casalini Patrizia; Carcangiu Maria Luisa; Tammi Raija; Auvinen Päivi; Kosma Veli-Matti; Valagussa Pinuccia; Greco Marco; Balsari Andrea; Ménard Sylvie; Tagliabue Elda
Two distinct local relapse subtypes in invasive breast cancer: effect on their prognostic impact.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(1):25-31.
2007: Demicheli Romano; Hrushesky William J M; Retsky Michael W; Bonadonna Gianni; Valagussa Pinuccia
Comment to "Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and intact primary tumor" by G V Babiera, R Rao, L Feng, F Meric-Bernstam, H M Kuerer, S E Singletary, K K Hunt, M I Ross, K M Gwyn, B W Feig, F C Ames, G N Horthobagyi. Ann Surg Oncol 2006;13:776-782.
Annals of surgical oncology 2007;14(4):1519-20.
2006: Mariani Gabriella; Petrelli Fausto; Zambetti Milvia; Moliterni Angela; Fasolo Angelica; Marchiano Alfonso; Valagussa Pinuccia; Gianni Luca
Capecitabine/Cyclophosphamide/Methotrexate for patients with metastatic breast cancer: a dose-finding, feasibility, and efficacy study.
Clinical breast cancer 2006;7(4):321-5.
2006: Corradini P; Tarella C; Zallio F; Dodero A; Zanni M; Valagussa P; Gianni A M; Rambaldi A; Barbui T; Cortelazzo S
Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(9):1533-8.
2006: Demicheli Romano; Bonadonna Gianni; Greco Marco; Hrushesky William J M; Moliterni Angela; Retsky Michael W; Valagussa Pinuccia; Zambetti Milvia
Comment to Anderson WF, Jatoi I, Devesa SS: distinct breast cancer incidence and prognostic patterns in the NCI'S SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005.
Breast cancer research and treatment 2006;97(3):341-3.
2006: Kaufmann Manfred; Hortobagyi Gabriel N; Goldhirsch Aron; Scholl Suzy; Makris Andreas; Valagussa Pinuccia; Blohmer Jens-Uwe; Eiermann Wolfgang; Jackesz Raimund; Jonat Walter; Lebeau Annette; Loibl Sibylle; Miller William; Seeber Sigfried; Semiglazov Vladimir; Smith Roy; Souchon Rainer; Stearns Vered; Untch Michael; von Minckwitz Gunter
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1940-9.
2005: Gianni Luca; Baselga José; Eiermann Wolfgang; Guillem Porta Vicente; Semiglazov Vladimir; Lluch Aña; Zambetti Milvia; Sabadell Dolores; Raab Günther; Llombart Cussac Antonio; Bozhok Alla; Martinez-Agulló Angel; Greco Marco; Byakhov Mikhail; Lopez Lopez Juan Josè; Mansutti Mauro; Valagussa Pinuccia; Bonadonna Gianni;
Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8715-21.
2005: Gianni Luca; Zambetti Milvia; Clark Kim; Baker Joffre; Cronin Maureen; Wu Jenny; Mariani Gabriella; Rodriguez Jaime; Carcangiu Marialuisa; Watson Drew; Valagussa Pinuccia; Rouzier Roman; Symmans W Fraser; Ross Jeffrey S; Hortobagyi Gabriel N; Pusztai Lajos; Shak Steven
Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(29):7265-77.
2005: Demicheli Romano; Bonadonna Gianni; Valagussa Pinuccia; Retsky Michael W; Hrushesky William J M; Baum Michael
Comment to Jatoi et al. report.
Breast cancer research and treatment 2005;93(1):1-2.
2005: Corradini P; Zallio F; Mariotti J; Farina L; Bregni M; Valagussa P; Ciceri F; Bacigalupo A; Dodero A; Lucesole M; Patriarca F; Rambaldi A; Scimè R; Locasciulli A; Bandini G; Gianni A M; Tarella C; Olivieri A
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6690-8.
2005: Demicheli R; Miceli R; Moliterni A; Zambetti M; Hrushesky W J M; Retsky M W; Valagussa P; Bonadonna G
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(9):1449-57.
2005: Bonadonna Gianni; Viviani Simonetta; Bonfante Valeria; Gianni Alessandro M; Valagussa Pinuccia
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
European journal of cancer (Oxford, England : 1990) 2005;41(7):998-1006.
2005: Bonadonna Gianni; Moliterni Angela; Zambetti Milvia; Daidone Maria Grazia; Pilotti Silvana; Gianni Luca; Valagussa Pinuccia
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study.
BMJ (Clinical research ed.) 2005;330(7485):217.
2004: Terenziani Monica; Spreafico Filippo; Collini Paola; Piva Luigi; Perotti Daniela; Podda Marta; Gandola Lorenza; Massimino Maura; Cereda Stefano; Cefalo Graziella; Luksch Roberto; Casanova Michela; Ferrari Andrea; Polastri Daniela; Valagussa Pinuccia; Fossati-Bellani Franca
Adult Wilms' tumor: A monoinstitutional experience and a review of the literature.
Cancer 2004;101(2):289-93.
2004: Bonadonna Gianni; Bonfante Valeria; Viviani Simonetta; Di Russo Anna; Villani Fabrizio; Valagussa Pinuccia
ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2835-41.
2004: Bonadonna Gianni; Zambetti Milvia; Moliterni Angela; Gianni Luca; Valagussa Pinuccia
Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and Fluorouracil in operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1614-20.
2004: Massimino Maura; Gandola Lorenza; Giangaspero Felice; Sandri Alessandro; Valagussa Pinuccia; Perilongo Giorgio; Garrè Maria Luisa; Ricardi Umberto; Forni Marco; Genitori Lorenzo; Scarzello Giovanni; Spreafico Filippo; Barra Salvina; Mascarin Maurizio; Pollo Bianca; Gardiman Martina; Cama Armando; Navarria Pierina; Brisigotti Maurizio; Collini Paola; Balter Rita; Fidani Paola; Stefanelli Maurizio; Burnelli Roberta; Potepan Paolo; Podda Marta; Sotti Guido; Madon Enrico;
Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.
International journal of radiation oncology, biology, physics 2004;58(5):1336-45.
2004: Demicheli Romano; Bonadonna Gianni; Hrushesky William J M; Retsky Michael W; Valagussa Pinuccia
Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):102-7.
2004: Demicheli Romano; Bonadonna Gianni; Hrushesky William J M; Retsky Michael W; Valagussa Pinuccia
Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.
Breast cancer research : BCR 2004;6(6):R689-96.
2004: Retsky Michael; Bonadonna Gianni; Demicheli Romano; Folkman Judah; Hrushesky William; Valagussa Pinuccia
Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients.
Breast cancer research : BCR 2004;6(4):R372-4.
2003: Corradini Paolo; Cavo Michele; Lokhorst Henk; Martinelli Giovanni; Terragna Carolina; Majolino Ignazio; Valagussa Pinuccia; Boccadoro Mario; Samson Diana; Bacigalupo Andrea; Russell Nigel; Montefusco Vittorio; Voena Claudia; Gahrton Gosta;
Molecular remission after myeloablative allogeneic stem cell transplantation predicts a better relapse-free survival in patients with multiple myeloma.
Blood 2003;102(5):1927-9.
2003: Campiglio Manuela; Somenzi Giulia; Olgiati Clelia; Beretta Giovanni; Balsari Andrea; Zaffaroni Nadia; Valagussa Pinuccia; Ménard Sylvie
Role of proliferation in HER2 status predicted response to doxorubicin.
International journal of cancer. Journal international du cancer 2003;105(4):568-73.
2003: Gamel John W; Bonadonna Gianni; Valagussa Pinuccia; Edwards Michael J
Refined measurement of outcome for adjuvant breast carcinoma therapy.
Cancer 2003;97(5):1139-46.
2003: Licitra L; Locati L D; Cavina R; Garassino I; Mattavelli F; Pizzi N; Quattrone P; Valagussa P; Gianni L; Bonadonna G; Solero C L; Cantu G
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):367-72.
2003: Moliterni Angela; Ménard Sylvie; Valagussa Pinuccia; Biganzoli Elia; Boracchi Patrizia; Balsari Andrea; Casalini Patrizia; Tomasic Gorana; Marubini Ettore; Pilotti Silvana; Bonadonna Gianni
HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):458-62.
2003: Licitra Lisa; Grandi Cesare; Guzzo Marco; Mariani Luigi; Lo Vullo Salvatore; Valvo Francesca; Quattrone Pasquale; Valagussa Pinuccia; Bonadonna Gianni; Molinari Roberto; Cantù Giulio
Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):327-33.
2003: Valagussa Pinuccia; Bonadonna Gianni
Breast cancer.
Cancer chemotherapy and biological response modifiers 2003;21():585-608.
2002: Demicheli R; Valagussa P; Bonadonna G
Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomy.
Breast cancer research and treatment 2002;75(2):127-34.
2002: Bonadonna G; Zambetti M; Bumma C; Donadio M; Bolognesi A; Robustelli Della Cuna G; Ambrosini G; Lelli G; Mansutti M; Verderio P; Valagussa P
Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1049-58.
2002: Bidoli Paolo; Bajetta Emilio; Stani Simonetta C; De Candis Daniela; Santoro Armando; Valente Maurizio; Zucali Roberto; Valagussa Pinuccia; Ravasi Gianni; Bonadonna Gianni
Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus.
Cancer 2002;94(2):352-61.
2002: Valagussa Pinuccia; Bonadonna Gianni
Breast cancer.
Cancer chemotherapy and biological response modifiers 2002;20():493-517.
2001: Mariani G; Tagliabue P; Zucchinelli P; Brambilla C; Demicheli R; Villa E; Marchianò A; Valagussa P; Bonadonna G; Gianni L
Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer.
Breast cancer research and treatment 2001;70(3):163-9.
2001: Demicheli R; Valagussa P; Bonadonna G
Does surgery modify growth kinetics of breast cancer micrometastases?
British journal of cancer 2001;85(4):490-2.
2001: Bonfante V; Viviani S; Devizzi L; Di Russo A; Di Nicola M; Magni M; Matteucci P; Grisanti S; Valagussa P; Bonadonna G; Gianni A M
High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease.
European journal of haematology. Supplementum 2001;64():51-5.
2001: Grasselli G; Viganò L; Capri G; Locatelli A; Tarenzi E; Spreafico C; Bertuzzi A; Giani A; Materazzo C; Cresta S; Perotti A; Valagussa P; Gianni L
Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2222-31.
2001: Gianni L; Valagussa P; Zambetti M; Moliterni A; Capri G; Bonadonna G
Adjuvant and neoadjuvant treatment of breast cancer.
Seminars in oncology 2001;28(1):13-29.
2001: Ménard S; Valagussa P; Pilotti S; Gianni L; Biganzoli E; Boracchi P; Tomasic G; Casalini P; Marubini E; Colnaghi M I; Cascinelli N; Bonadonna G
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):329-35.
2001: Zambetti M; Moliterni A; Materazzo C; Stefanelli M; Cipriani S; Valagussa P; Bonadonna G; Gianni L
Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):37-43.
2001: Valagussa P; Bonadonna G
Breast cancer.
Cancer chemotherapy and biological response modifiers 2001;19():597-628.
2000: Greco M; Gennaro M; Valagussa P; Agresti R; Ferraris C; Ferrari B; Urban C; Gianni L
Impact of nodal status on indication for adjuvant treatment in clinically node negative breast cancer. Istituto Nazionale per lo Studio e las Cura dei Tumori.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(9):1137-40.
2000: Silvestrini R; Luisi A; Zambetti M; Cipriani S; Valagussa P; Bonadonna G; Daidone M G
Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer.
International journal of cancer. Journal international du cancer 2000;87(3):405-11.
2000: Tondini C; Balzarotti M; Rampinelli I; Valagussa P; Luoni M; De Paoli A; Santoro A; Bonadonna G
Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):231-3.
2000: Viviani S; Notti P; Bonfante V; Verderio P; Valagussa P; Bonadonna G
Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience.
Medical oncology (Northwood, London, England) 2000;17(1):59-63.
1999: Veronesi U; Marubini E; Mariani L; Valagussa P; Zucali R
The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial.
European journal of cancer (Oxford, England : 1990) 1999;35(9):1320-5.
1999: Tondini C; Ferreri A J; Siracusano L; Valagussa P; Giardini R; Rampinelli I; Bonadonna G
Diffuse large-cell lymphoma of the testis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2854-8.
1999: Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo A D; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G
Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
The cancer journal from Scientific American 1999;5(5):275-82.
1999: Zambetti M; Oriana S; Quattrone P; Verderio P; Terenziani M; Zucali R; Valagussa P; Bonadonna G
Combined sequential approach in locally advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(3):305-10.
1999: Demicheli R; Miceli R; Brambilla C; Ferrari L; Moliterni A; Zambetti M; Valagussa P; Bonadonna G
Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'.
Breast cancer research and treatment 1999;53(3):209-15.
1998: Bonfante V; Viviani S; Santoro A; Devizzi L; Di Russo A; Zanini M; Soncini F; Soto Parra H; Valagussa P; Bonadonna G
Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's disease.
British journal of haematology 1998;103(2):533-5.
1998: Edwards M J; Bonadonna G; Valagussa P; Gamel J W
End points in the analysis of breast cancer survival: relapse versus death from tumor.
Surgery 1998;124(2):197-202.
1998: Viviani S; Camerini E; Bonfante V; Santoro A; Balzarotti M; Fornier M; Devizzi L; Verderio P; Valagussa P; Bonadonna G
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
British journal of cancer 1998;77(6):992-7.
1998: Bonadonna G; Valagussa P; Brambilla C; Ferrari L; Moliterni A; Terenziani M; Zambetti M
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):93-100.
1998: Gianni L; Capri G; Valagussa P; Bonadonna G
Putting taxanes to work in operable breast cancer: a search for selective indications from empirical studies.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;152():314-22.
1997: Moliterni A; Tarenzi E; Capri G; Terenziani M; Bertuzzi A; Grasselli G; Agresti R; Piotti P; Greco M; Salvadori B; Pilotti S; Lombardi F; Valagussa P; Bonadonna G; Gianni L
Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-10-S17-14.
1997: Retsky M W; Demicheli R; Swartzendruber D E; Bame P D; Wardwell R H; Bonadonna G; Speer J F; Valagussa P
Computer simulation of a breast cancer metastasis model.
Breast cancer research and treatment 1997;45(2):193-202.
1997: Gianni A M; Siena S; Bregni M; Di Nicola M; Orefice S; Cusumano F; Salvadori B; Luini A; Greco M; Zucali R; Rilke F; Zambetti M; Valagussa P; Bonadonna G
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2312-21.
1997: Gianni A M; Bregni M; Siena S; Brambilla C; Di Nicola M; Lombardi F; Gandola L; Tarella C; Pileri A; Ravagnani F; Valagussa P; Bonadonna G
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.
The New England journal of medicine 1997;336(18):1290-7.
1997: Bonfante V; Santoro A; Viviani S; Devizzi L; Balzarotti M; Soncini F; Zanini M; Valagussa P; Bonadonna G
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):528-34.
1997: Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():53-6.
1996: Bonadonna G; Valagussa P
Primary chemotherapy in operable breast cancer.
Seminars in oncology 1996;23(4):464-74.
1996: Zambetti M; Valagussa P; Bonadonna G
Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):481-5.
1996: Viviani S; Bonadonna G; Santoro A; Bonfante V; Zanini M; Devizzi L; Soncini F; Valagussa P
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1421-30.
1996: Zambetti M; Terenziani M; Bartoli C; Valagussa P; Piotti P; Ferranti C; Bonadonna G
Intermediate doses of cyclophosphamide alone or following adriamycin in advanced breast cancer. A pilot study.
American journal of clinical oncology 1996;19(1):82-6.
1996: Demicheli R; Abbattista A; Miceli R; Valagussa P; Bonadonna G
Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.
Breast cancer research and treatment 1996;41(2):177-85.
1996: Valagussa P; De Candis D; Antonelli G; Bonadonna G
VIII. Women's health perception and breast cancer: issues of fertility, hormone substitution, and cancer prevention.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;140():277-83.
1995: Bonadonna G; Valagussa P; Moliterni A; Zambetti M; Brambilla C
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up.
The New England journal of medicine 1995;332(14):901-6.
1995: Santoro A; Parra H S; Bidoli P; Angelidou M; Cataldo I; Salvini P; Valagussa P; Milani F; Ravasi G; Bonadonna G
A summary of the Milan experience with multimodality therapies in patients with small cell lung cancer: attempts to improve long-term outcome.
Seminars in oncology 1995;22(1 Suppl 2):9-14.
1994: Valagussa P; Moliterni A; Terenziani M; Zambetti M; Bonadonna G
Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):803-8.
1994: Devizzi L; Santoro A; Bonfante V; Viviani S; Balzarini L; Valagussa P; Bonadonna G
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):817-20.
1994: Valagussa P; Zambetti M; Biasi S; Moliterni A; Zucali R; Bonadonna G
Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):209-16.
1994: Demicheli R; Terenziani M; Valagussa P; Moliterni A; Zambetti M; Bonadonna G
Local recurrences following mastectomy: support for the concept of tumor dormancy.
Journal of the National Cancer Institute 1994;86(1):45-8.
1993: Tondini C; Giardini R; Bozzetti F; Valagussa P; Santoro A; Bertulli R; Balzarotti M; Rocca A; Lombardi F; Ferreri A J
Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(10):831-7.
1993: Bonadonna G; Gianni L; Santoro A; Bonfante V; Bidoli P; Casali P; Demicheli R; Valagussa P
Drugs ten years later: epirubicin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(5):359-69.
1993: Tondini C; Zanini M; Lombardi F; Bengala C; Rocca A; Giardini R; Buzzoni R; Valagussa P; Bonadonna G
Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):720-5.
1993: Valagussa P; Moliterni A; Zambetti M; Bonadonna G
Long-term sequelae from adjuvant chemotherapy.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():247-55.
1993: Bonadonna G; Veronesi U; Brambilla C; Ferrari L; Passoni P; Coopmans de Yoldi G F; Luini A; Greco M; Valagussa P
Primary chemotherapy for resectable breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():113-7.
1992: Valagussa P; Santoro A; Bonadonna G
Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():111-5.
1992: Bonfante V; Santoro A; Viviani S; Valagussa P; Bonadonna G
ABVD in the treatment of Hodgkin's disease.
Seminars in oncology 1992;19(2 Suppl 5):38-44; discussion 44-5.
1992: Bonfante V; Santoro A; Viviani S; Zucali R; Devizzi L; Zanini M; Tesoro Tess J D; Valagussa P; Banfi A; Bonadonna G
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP.
European journal of cancer (Oxford, England : 1990) 1992;29A(1):24-9.
1991: Buzzoni R; Bonadonna G; Valagussa P; Zambetti M
Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(12):2134-40.
1991: Bonadonna G; Valagussa P; Brambilla C; Moliterni A; Zambetti M; Ferrari L
Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy.
Seminars in oncology 1991;18(6):515-24.
1991: Gianni A M; Siena S; Bregni M; Lombardi F; Gandola L; Valagussa P; Bonadonna G
Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(9):645-53.
1991: Moliterni A; Bonadonna G; Valagussa P; Ferrari L; Zambetti M
Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(7):1124-30.
1991: Viviani S; Bonadonna G; Santoro A; Zanini M; Zucali R; Negretti E; Valagussa P
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():55-62.
1991: Viviani S; Ragni G; Santoro A; Perotti L; Caccamo E; Negretti E; Valagussa P; Bonadonna G
Testicular dysfunction in Hodgkin's disease before and after treatment.
European journal of cancer (Oxford, England : 1990) 1991;27(11):1389-92.
1990: Silvestrini R; Daidone M G; Valagussa P; Di Fronzo G; Mezzanotte G; Mariani L; Bonadonna G
3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(8):1321-6.
1990: Bonadonna G; Valagussa P
Influence of clinical trials on current treatment strategy for Hodgkin's disease.
International journal of radiation oncology, biology, physics 1990;19(1):209-18.
1990: Valagussa P; Zambetti M; Bonadonna G; Zucali R; Mezzanotte G; Veronesi U
Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy.
Breast cancer research and treatment 1990;15(3):137-47.
1990: Viviani S; Santoro A; Negretti E; Bonfante V; Valagussa P; Bonadonna G
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(2):123-7.
1989: Silvestrini R; Daidone M G; Valagussa P; Di Fronzo G; Mezzanotte G; Bonadonna G
Cell kinetics as a prognostic indicator in node-negative breast cancer.
European journal of cancer & clinical oncology 1989;25(8):1165-71.
1989: Valagussa P; Brambilla C; Zambetti M; Bonadonna G
Salvage treatments in relapsing resectable breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():69-76.
1989: Bonadonna G; Valagussa P; Zambetti M; Brambilla C
The Milan experience with adjuvant chemotherapy in premenopausal breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():113-7.
1989: Bonadonna G; Zambetti M; Valagussa P
Adjuvant chemotherapy for node-negative breast cancer patients.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():175-9.
1989: Bonadonna G; Valagussa P; Santoro A; Viviani S; Bonfante V; Banfi A
Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():169-74.
1988: Verusio C; Bajetta E; Ferrari L; Bartoli C; Valagussa P; Bonadonna G
Cyclophosphamide, adriamycin, and cis-platinum (CAP) in metastatic and locally advanced breast cancer.
American journal of clinical oncology 1988;11(4):435-9.
1988: Bajetta E; Valagussa P; Bonadonna G; Lattuada A; Buzzoni R; Rilke F; Banfi A
Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy.
International journal of radiation oncology, biology, physics 1988;15(1):3-12.
1988: Bajetta E; Buzzoni R; Valagussa P; Bonadonna G
Mitoxantrone: an active agent in refractory non-Hodgkin's lymphomas.
American journal of clinical oncology 1988;11(2):100-3.
1987: Ferrari L; Bajetta E; Gianni L; Verusio C; Bartoli C; Valagussa P; Bonadonna G
Four-drug sequential regimen in advanced breast cancer.
Breast cancer research and treatment 1987;10(2):151-7.
1987: Weiss R B; Valagussa P; Moliterni A; Zambetti M; Buzzoni R; Bonadonna G
Adjuvant chemotherapy after conservative surgery plus irradiation versus modified radical mastectomy. Analysis of drug dosing and toxicity.
The American journal of medicine 1987;83(3):455-63.
1986: Valagussa P; Santoro A; Fossati-Bellani F; Banfi A; Bonadonna G
Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(6):830-7.
1984: Bonadonna G; Bignami P; Buzzoni R; Moliterni A; Valagussa P; Veronesi U
New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1984;91():210-3.
1982: Valagussa P; Santoro A; Fossati Bellani F; Franchi F; Banfi A; Bonadonna G
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.
Blood 1982;59(3):488-94.
1981: Bonadonna G; Rossi A; Tancini G; Bajetta E; Marchini S; Brambilla C; Tesoro Tess J D; Valagussa P; Banfi A; Veronesi U
Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.
Cancer treatment reports 1981;65 Suppl 1():61-5.
1980: Monfardini S; Banfi A; Bonadonna G; Rilke F; Milani F; Valagussa P; Lattuada A
Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma.
International journal of radiation oncology, biology, physics 1980;6(2):125-34.
1980: Valagussa P; Santoro A; Kenda R; Fossati Bellani F; Franchi F; Banfi A; Rilke F; Bonadonna G
Second malignancies in Hodgkin's disease: a complication of certain forms of treatment.
British medical journal 1980;280(6209):216-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Pinuccia Valagussa

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Pinuccia Valagussa (preview)

All Publications